These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24919218)

  • 21. Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults.
    Ye BS
    Clin Mol Hepatol; 2022 Jul; 28(3):481-482. PubMed ID: 35570004
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.
    Hwang ST; Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Rhee EJ; Oh KW; Lee WY; Jin W
    Intern Med J; 2010 Jun; 40(6):437-42. PubMed ID: 19460054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].
    Lazebnik LB; Zvenigorodskaia LA; Egorova EG; Mel'nikova NV; Khomeriki SG
    Eksp Klin Gastroenterol; 2009; (8):4-11. PubMed ID: 20469672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of metabolic indexes in patients with type 2 diabetes and metabolic associated fatty liver disease.
    Wang Q; Chen X; Li H; Hua F
    Minerva Gastroenterol (Torino); 2024 Jun; 70(2):252-253. PubMed ID: 37232148
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter to the editor: Circulating thrombospondin-2 as a biomarker in patients with NAFLD with and without diabetes-Are we convinced yet?
    Lee CH; Lui DTW; Lam KSL
    Hepatology; 2022 May; 75(5):1340. PubMed ID: 35075677
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonalcoholic liver disease in metabolic syndrome/type II diabetes mellitus patients: it is necessary to identify alcohol consumption.
    Testino G; Pellicano R
    Minerva Endocrinol (Torino); 2022 Jun; 47(2):257-259. PubMed ID: 35195383
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease].
    Zhu QQ; Lou DJ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ; Li D
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):305-8. PubMed ID: 20627036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease, metabolic syndrome and gastric cancer: Single center experience.
    Uzel M; Sahiner Z; Filik L
    J BUON; 2015; 20(2):662. PubMed ID: 26011365
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathological features of fatty liver disease.
    Yeh MM; Brunt EM
    Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients.
    Bulum T; Kolarić B; Duvnjak M; Duvnjak L
    Ren Fail; 2014 Apr; 36(3):372-7. PubMed ID: 24455970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus.
    Iwasaki T; Yoneda M; Inamori M; Shirakawa J; Higurashi T; Maeda S; Terauchi Y; Nakajima A
    Hepatogastroenterology; 2011; 58(112):2103-5. PubMed ID: 22024083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
    Byrne CD
    Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pathogenesis and management of non-alcoholic fatty liver disease coexisted with type 2 diabetes].
    Liu Y; Hong T
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3565-7. PubMed ID: 26813365
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.
    Dyson J; Jaques B; Chattopadyhay D; Lochan R; Graham J; Das D; Aslam T; Patanwala I; Gaggar S; Cole M; Sumpter K; Stewart S; Rose J; Hudson M; Manas D; Reeves HL
    J Hepatol; 2014 Jan; 60(1):110-7. PubMed ID: 23978719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
    J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic fatty liver disease is associated with specific changes in blood-borne markers.
    Sharma S; Barrett F; Adamson J; Todd A; Megson IL; Zentler-Munro PL; MacRury SM
    Diabetes Metab Res Rev; 2012 May; 28(4):343-8. PubMed ID: 22576780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic Fatty Liver Disease in Human Immunodeficiency Virus: The (Not So) New Kid on the Block?
    Krahn T; Sebastiani G
    Clin Infect Dis; 2020 Jun; 71(1):243-244. PubMed ID: 31538647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.